An overview of GLP-1 receptor agonist research peptides — Semaglutide, Tirzepatide and Retatrutide — receptor pharmacology and research context. Laboratory use only.
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced in the intestinal L-cells in response to food intake. GLP-1 plays a critical role in glucose homeostasis by stimulating insulin secretion, suppressing glucagon release, and regulating gastric emptying. Research peptides targeting the GLP-1 receptor have become essential tools in metabolic and endocrine research.
The incretin system comprises two primary hormones: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). Together, they are responsible for the 'incretin effect' — the observation that oral glucose produces a greater insulin response than intravenous glucose at the same blood glucose levels. Understanding this system is fundamental to metabolic research, and synthetic peptide agonists provide researchers with precise tools to study each component.
Single agonists target only the GLP-1 receptor (e.g., semaglutide, liraglutide). Dual agonists such as tirzepatide target both GLP-1 and GIP receptors, allowing study of synergistic incretin effects. Triple agonists like retatrutide add glucagon receptor activity to the dual GLP-1/GIP mechanism, providing tools for studying three metabolic pathways simultaneously. Each class offers distinct advantages for specific research questions.
Glucose homeostasis studies. Insulin secretion pathway investigations. Gastric motility and emptying research. Beta-cell function and proliferation studies. Appetite and satiety signalling research. Cardiovascular effects of incretin signalling. Comparative agonist studies across receptor subtypes.
Single agonists are ideal for studying isolated GLP-1 receptor effects. Dual agonists (tirzepatide) are suited for investigating GLP-1/GIP pathway interactions. Triple agonists (retatrutide) enable comprehensive study of GLP-1, GIP, and glucagon receptor cross-talk. Consider your specific research questions when selecting between these options, and review the available literature on each compound.
When sourcing GLP-1 peptides for research, purity is paramount. Look for suppliers providing HPLC and mass spectrometry verified purity of ≥99%. Full Certificates of Analysis should be available for every batch. Proper storage at -20°C (lyophilised) is essential for maintaining peptide integrity. All Neovia Peptides GLP-1 products are verified to our stringent quality standards.
Research-grade compounds referenced in this guide, supplied with full Certificates of Analysis.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
